Wurzburg, Germany

Andreas Zettl



Average Co-Inventor Count = 34.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Würzburg, DE (2012)
  • Wurzburg, DE (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Andreas Zettl

Introduction

Andreas Zettl is a notable inventor based in Wurzburg, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of lymphomas. With a total of two patents to his name, Zettl's work focuses on improving the identification and treatment of lymphoproliferative disorders.

Latest Patents

Zettl's latest patents revolve around methods for identifying, diagnosing, and predicting survival in lymphomas. His inventions utilize gene expression data to enhance the accuracy of diagnosing lymphoproliferative disorders. The present invention introduces the Lymph Dx microarray, which is designed to obtain gene expression data from lymphoma samples. This innovative approach allows for the identification of specific lymphomas and the prediction of survival outcomes for patients diagnosed with these conditions. The information derived from these methods is crucial for developing tailored therapeutic strategies for individual patients.

Career Highlights

Throughout his career, Zettl has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University of Nebraska. His experience in these institutions has contributed to his expertise in medical research and innovation.

Collaborations

Some of Zettl's notable coworkers include George Wright and Bruce Tan. Their collaborative efforts have likely played a role in advancing the research and development of Zettl's inventions.

Conclusion

Andreas Zettl's contributions to the field of lymphoma diagnostics exemplify the impact of innovative research in medicine. His patents not only enhance diagnostic accuracy but also pave the way for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…